Knight Jeff E.'s Form 4 filing
Crinetics Pharmaceuticals, Inc. (CRNX) · filed Jul 29, 2022
- Accession no.
- 0001209191-22-043524
- Filed
- Jul 29, 2022
- Trade date
- May 20-Jul 26, 2022
- Filing delay
- 70 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $23.8K. It was filed 70 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Knight Jeff E.CIK 0001881007 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 20, 2022 | Common Stock | JOtherAcquired | +1,152 | $17.44 | +$20,090.88 | 6,102 | Direct | |
| Jul 26, 2022 | Common Stock | SSaleDisposed | −1,152 | $20.70 | −$23,846.4 | 4,950 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.